ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,600Medicare Part D Prescriptions Filled, Including Refills

Rank: 225 out of 939

$465K Total Retail Price of All Prescriptions

Rank: 286 out of 939

390 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 390 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 390 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 8,231 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 436 357 1 2
OMEPRAZOLE 415 306 2 5
HYDROCODONE-ACETAMINOPHEN 393 248 S3 3 1
LEVOTHYROXINE SODIUM 373 301 4 4
FUROSEMIDE 301 272 5 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 210 152 6 23
AMLODIPINE BESYLATE 201 190 7 6
METOPROLOL SUCCINATE 199 165 8 21
METOPROLOL TARTRATE 188 141 9 10
HYDROCHLOROTHIAZIDE 183 170 10 12
WARFARIN SODIUM 178 161 11 17
POTASSIUM CHLORIDE 176 102 12 9
METFORMIN HCL 175 120 13 8
DONEPEZIL HCL 163 151 14 30
SERTRALINE HCL 161 127 15 24
LISINOPRIL 147 110 16 3
ATORVASTATIN CALCIUM 146 105 17 22
AMOXICILLIN 131 88 18 92
MELOXICAM 121 83 19 14
NAPROXEN 121 52 19 72
GABAPENTIN 121 100 19 11
ZOLPIDEM TARTRATE 113 77 22 20
ALLOPURINOL 108 78 23 31
TRAMADOL HCL 96 66 24 16
KLOR-CON M20 96 82 24 90
CLONIDINE HCL 94 75 26 39
PREDNISONE 93 80 27 42
GLIPIZIDE 93 67 27 52
ATENOLOL 92 90 29 19
RANITIDINE HCL 90 74 30 35
CITALOPRAM HBR 85 71 31 15
LOSARTAN-HYDROCHLOROTHIAZIDE 83 57 32 55
IPRATROPIUM-ALBUTEROL 82 82 33 178
TAMSULOSIN HCL 81 72 34 27
CLOPIDOGREL 79 67 35 28
TRIAMTERENE-HCTZ 78 59 36 33
VERAPAMIL ER 70 68 37 85
LOSARTAN POTASSIUM 64 40 38 29
PROMETHAZINE HCL 64 26 R 38 68
CEFPROZIL 62 53 40 213
CEPHALEXIN 61 49 41 77
ATENOLOL-CHLORTHALIDONE 60 23 42 164
GLIPIZIDE XL 59 59 43 147
PRAVASTATIN SODIUM 58 41 44 13
CIPROFLOXACIN HCL 58 41 44 54
CRESTOR 58 48 44 34
DIGOXIN 58 56 44 45
POLYETHYLENE GLYCOL 3350 57 38 48 57
DIOVAN 56 43 49 50
ISOSORBIDE MONONITRATE ER 56 38 49 53
ENALAPRIL MALEATE 56 34 49 65
PLAVIX 56 52 49 48
RAMIPRIL 55 41 53 91
GLIPIZIDE ER 52 45 54 88
LEVOFLOXACIN 51 37 55 86
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.